The European Pharmaceutical Wholesale Industry: - phagro

More documents

Recommendations

Info

23 75 74 73 72 71 70 The European Pharmaceutical Wholesale Industry Figure 17: Demographic Changes in the EU-22, 1990-2003 Life expectancy at birth % of population 23.48% 71,0 11.04% 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 Life expectancy at birth % of population aged 65+ % of population aged 0-14 Source: WHO European Health for All Database 74,3 16.96% 13.55% As third factor influencing the overall level of consumption, medical progress must be identified. As biotechnological, genomic and proteomic sciences advance, new ways for the treatment of diseases are discovered. Consequently, pharmacological therapy can be applied in cases where in the past there was no treatment at all, or, for example, surgery was needed. 4.3 Employment From 2000 to 2004, employment in the pharmaceutical wholesale sector of the EU-15 went down by 875 from 66,613 to 65,738 working places, measured in full time equivalents (FTE). The downturn in the number of employees is the direct result of market consolidation, reducing the overall number of wholesalers, especially in Italy. Employment reached a low in 2002, improving constantly since then, although sales growth was reduced from 2003 to 2004 from 6.16% to 3.51%. From a managerial point of view, the diverse development of sales and employment dampens the branch’s productivity. But from an economic-policy point of view the development was positive, since pharmaceutical wholesalers created additional jobs despite a difficult market situation. IPF Institute for Pharmaeconomic Research 26 24 22 20 18 16 14 12 10
The European Pharmaceutical Wholesale Industry Figure 18: Development of Sales and Employment (FTE) of Pharmaceutical full-line Wholesalers 1) in the EU-15, 2000-2004 68.000 67.000 66.000 65.000 64.000 63.000 Employees Turnover (in million EUR) 66,613 76,714 2000 2001 2002 2003 2004 1) Estimates for UK and NL Employees Turnover Source: GIRP data 2004, IPF research 96,004 65,738 100000 95000 90000 85000 80000 75000 70000 The six biggest wholesale markets (in terms of sales) France, Germany, Italy, the Netherlands, Spain and the UK employed around 83% of the staff engaged in pharmaceutical wholesaling in the EU-15 in 2004. Figure 19: Employees (FTE) at Pharmaceutical full-line Wholesalers, 2004 14000 12000 10000 8000 6000 4000 2000 0 13,000 12,790 12,230 9,000 7,900 1,840 1,610 GER FR IT UK ESP NL AUT Source: GIRP data, IPF research IPF Institute for Pharmaeconomic Research 24
Page 1: ��
Page 4 and 5: Contents a The European Pharmaceuti
Page 6 and 7: Figures c The European Pharmaceutic
Page 8 and 9: The European Pharmaceutical Wholesa
Page 10 and 11: III The European Pharmaceutical Who
Page 12 and 13: V The European Pharmaceutical Whole
Page 14 and 15: VII The European Pharmaceutical Who
Page 18 and 19: 1 Introduction 1 The European Pharm
Page 22 and 23: 5 The European Pharmaceutical Whole
Page 28 and 29: 11 The European Pharmaceutical Whol
Page 60 and 61: 43 40 35 30 25 20 15 10 5 0 The Eur
Page 86 and 87: 9 Bibliography 69 The European Phar

The European Pharmaceutical Wholesale Industry: - phagro

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?